MONAHAN MICHAEL P. 4

What Happened

• Michael P. Monahan, Chief Financial Officer of Beauty Health Company (ticker: SKIN), received a grant of 746,681 restricted stock units (RSUs) on March 20, 2026. The award is reported on a Form 4 as transaction type "A" (award/grant). No cash price was paid; the RSUs are a form of equity compensation that may convert into shares if vesting conditions are met.

Key Details

• Transaction date: 2026-03-20; Form 4 filed: 2026-03-24 (filed timely).
• Transaction code: A (award/grant). Price per share: N/A for RSUs (no purchase price).
• Shares granted: 746,681 RSUs. Reported value not specified in the filing.
• Shares owned after transaction: Not disclosed in the provided filing details.
• Footnote (F1): Each RSU is a contingent right to one share of Class A common stock. RSUs vest in three equal installments (one-third each) on each of the first three anniversaries of the March 20, 2026 grant date, subject to continued service and certain acceleration rights.

Context

• RSU grants are compensation, not market purchases or sales; they do not necessarily signal buying or selling intent by the insider. Vesting is time-based, so shares will only be delivered if Monahan remains employed (or an acceleration event occurs).
• For retail investors tracking insider activity, grants show how the company is compensating executives but are less immediately informative about insider sentiment than open-market purchases or sales.